Cysteine-rich 61 (CYR61) inhibits cisplatin-induced apoptosis in ovarian carcinoma cells

被引：0
|
作者：
Seung Bae Rho
Jong Soo Woo
Taehoon Chun
Sang-Yoon Park
机构：
[1] National Cancer Center,Research Institute
[2] Korea University,Division of Biotechnology, College of Life Sciences and Biotechnology
[3] National Cancer Center,Center for Uterine Cancer, Research Institute and Hospital
来源：
Biotechnology Letters | 2009年 / 31卷 / 1期
关键词：
D O I：
10.1007/s10529-008-9876-1
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：29 / 29
相关论文
共 50 条
  • [21] Cysteine-rich, angiogenic inducer, 61 expression in patients with ovarian epithelial carcinoma
    Lin, Yang
    Xu, Tianmin
    Tian, Geng
    Cui, Manhua
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2014, 42 (02) : 300 - 306
  • [22] CYR61 overexpression associated with the development and poor prognosis of ovarian carcinoma
    Shen, Huimin
    Cai, Muyan
    Zhao, Shanshan
    Wang, Huan
    Li, Mengxiong
    Yao, Shuzhong
    Jiang, Nan
    [J]. MEDICAL ONCOLOGY, 2014, 31 (08)
  • [23] Matricellular Protein Cysteine-Rich Angiogenic Inducer 61 (CCN1/CYR61) - A Potential Therapeutic Target to Lower Intraocular Pressure.
    Pattabiraman, P. P.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [24] Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acutemyocardial injury improves risk stratification after acute coronary syndromes
    Klingenberg, Roland
    Aghlmandi, Soheila
    Liebetrau, Christoph
    Raber, Lorenz
    Gencer, Baris
    Nanchen, David
    Carballo, David
    Akhmedov, Alexander
    Montecucco, Fabrizio
    Zoller, Stefan
    Brokopp, Chad
    Heg, Dik
    Juni, Peter
    Soler, Helena Marti
    Marques-Vidal, Pedro-Manuel
    Vollenweider, Peter
    Dorr, Oliver
    Rodondi, Nicolas
    Mach, Francois
    Windecker, Stephan
    Landmesser, Ulf
    von Eckardstein, Arnold
    Hamm, Christian W.
    Matter, Christian M.
    Luscher, Thomas F.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (47) : 3493 - +
  • [25] Blood-based detection of lung cancer using cysteine-rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study
    Ackar, Lucija
    Casjens, Swaantje
    Andreas, Antje
    Raiko, Irina
    Bruening, Thomas
    Geffken, Maria
    Peine, Sven
    Kollmeier, Jens
    Johnen, Georg
    Bartkowiak, Kai
    Weber, Daniel Gilbert
    Pantel, Klaus
    [J]. MOLECULAR ONCOLOGY, 2021, 15 (11) : 2877 - 2890
  • [26] CYR61 overexpression associated with the development and poor prognosis of ovarian carcinoma
    Huimin Shen
    Muyan Cai
    Shanshan Zhao
    Huan Wang
    Mengxiong Li
    Shuzhong Yao
    Nan Jiang
    [J]. Medical Oncology, 2014, 31
  • [27] RETRACTED: Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway (Retracted Article)
    Zhang, Fengli
    Chen, Huixiao
    Du, Jing
    Wang, Bin
    Yang, Lixiao
    [J]. MEDICAL SCIENCE MONITOR, 2018, 24 : 6093 - 6101
  • [28] Circulating Cysteine Rich Protein 61 (Cyr61, CCN1) in Chinese Adults: Distribution and Reference Intervals
    Li, Haichuan
    Zhang, Yan
    Qiu, Zhaohui
    Li, Huidan
    Zhuang, Wenfang
    Huo, Rongfen
    Lin, Jinpiao
    Ou, Qishui
    Shen, Baihua
    Zhai, Tianhang
    Zhang, Jie
    Yu, Jing
    Sheng, Huiming
    Li, Ningli
    [J]. CLINICAL LABORATORY, 2021, 67 (03) : 674 - 680
  • [29] Zoledronic acid induces down-regulation of cysteine-rich, angiogenic inducer, 61 (CYR61) expression in androgen-resistant prostate cancer cells PC3
    Santini, D.
    Caraglia, M.
    Vincenzi, B.
    Altucci, L.
    Bertieri, R.
    Addeo, S. R.
    Rosolowski, M.
    Loeffler, M.
    Budillon, A.
    Baldi, A.
    Tonini, G.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI27 - XI27
  • [30] Elevated Cysteine-rich protein 61 (CYR61/CCN1) mediates down-regulation of collagen expression in senescent human dermal fibroblasts.
    Quan, T.
    Qin, Z.
    He, T.
    Voorhees, J. J.
    Fisher, C. J.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S33 - S33
12345